Novo Nordisk's pricing strategies within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, pointing out the stark distinction concerning U.S. charges and those in Europe and copyright.The company suggests that right use of copyright, coupled with diet and training, "may help less